Can We Use Lung Function Thresholds and Respiratory Symptoms to Identify Pre-Chronic Obstructive Pulmonary Disease? A Prospective, Population-based Cohort Study

被引:4
|
作者
Tan, Daniel J. [1 ]
Lodge, Caroline J. [1 ]
Walters, E. Haydn [1 ,2 ]
Bui, Dinh S. [1 ]
Pham, Jonathan [1 ,3 ]
Lowe, Adrian J. [1 ]
Bowatte, Gayan [1 ,4 ]
Vicendese, Don [1 ,5 ]
Erbas, Bircan [6 ,7 ]
Johns, David P. [1 ,2 ]
James, Alan L. [8 ]
Frith, Peter [9 ]
Hamilton, Garun S. [10 ,11 ]
Thomas, Paul S. [13 ]
Wood-Baker, Richard [2 ]
Han, MeiLan K. [14 ]
Washko, George R. [15 ]
Abramson, Michael J. [12 ]
Perret, Jennifer L. [1 ,16 ,17 ]
Dharmage, Shyamali C. [1 ]
机构
[1] Univ Melbourne, Sch Populat & Global Hlth, Allergy & Lung Hlth Unit, Ctr Epidemiol & Biostat, Level 3,207 Bouverie St, Melbourne, Vic 3052, Australia
[2] Univ Tasmania, Sch Med, Hobart, Tas, Australia
[3] Alfred Hosp, Allergy Asthma & Clin Immunol, Melbourne, Vic, Australia
[4] Univ Peradeniya, Fac Allied Hlth Sci, Dept Basic Sci, Peradeniya, Sri Lanka
[5] La Trobe Univ Melbourne, Sch Engn & Math Sci, Melbourne, Vic, Australia
[6] La Trobe Univ Melbourne, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia
[7] La Trobe Univ, Violet Vines Marshman Ctr Rural Hlth Res, Bendigo, Vic, Australia
[8] Sir Charles Gairdner Hosp, Dept Pulm Physiol & Sleep Med, Nedlands, WA, Australia
[9] Flinders Univ S Australia, Coll Med & Publ Hlth, Adelaide, SA, Australia
[10] Monash Hlth, Monash Lung Sleep Allergy Immunol, Melbourne, Vic, Australia
[11] Monash Univ, Sch Clin Sci, Melbourne, Vic, Australia
[12] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia
[13] Univ New S Wales, Sch Clin, Fac Med, Sydney, NSW, Australia
[14] Univ Michigan Hlth Syst, Div Pulm & Crit Care Med, Ann Arbor, MI USA
[15] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA USA
[16] Inst Breathing & Sleep, Melbourne, Vic, Australia
[17] Austin Hlth, Dept Resp & Sleep Med, Melbourne, Vic, Australia
基金
英国医学研究理事会;
关键词
COPD; pre-COPD; spirometry; diffusing capacity; lung volumes; SPIROMETRY; STANDARDIZATION; HEALTH; RISK; COPD;
D O I
10.1164/rccm.202212-2330OC
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Rationale: The term "pre-chronic obstructive pulmonary disease" ("pre-COPD") refers to individuals at high risk of developing COPD who do not meet conventional spirometric criteria for airflow obstruction. New approaches to identifying these individuals are needed, particularly in younger populations. Objectives: To determine whether lung function thresholds and respiratory symptoms can be used to identify individuals at risk of developing COPD. Methods: The Tasmanian Longitudinal Health Study comprises a population-based cohort first studied in 1968 (at age 7 yr). Respiratory symptoms, pre- and post-bronchodilator (BD) spirometry, diffusing capacity, and static lung volumes were measured in a subgroup at age 45, and the incidence of COPD was assessed at age 53. For each lung function measure, z-scores were calculated using Global Lung Function Initiative references. The optimal threshold for best discrimination of COPD incidence was determined by the unweighted Youden index. Measurements and Main Results: Among 801 participants who did not have COPD at age 45, the optimal threshold for COPD incidence by age 53 was pre-BD FEV1/FVC z-score less than 21.264, corresponding to the lowest 10(th) percentile. Those below this threshold had a 36-fold increased risk of developing COPD over an 8-year follow-up period (risk ratio, 35.8; 95% confidence interval, 8.88 to 144), corresponding to a risk difference of 16.4% (95% confidence interval, 3.7 to 67.4). The sensitivity was 88%, and the specificity was 87%. Positive and negative likelihood ratios were 6.79 and 0.14, respectively. Respiratory symptoms, post-BD spirometry, diffusing capacity, and static lung volumes did not improve on the classification achieved by pre-BD FEV1/FVC alone. Conclusions: This is the first study, to our knowledge, to evaluate the discriminatory accuracy of spirometry, diffusing capacity, and static lung volume thresholds for COPD incidence in middle-aged adults. Our findings support the inclusion of preBD spirometry in the physiological definition of pre-COPD and indicate that pre-BD FEV1/FVC at the 10(th) percentile accurately identifies individuals at high risk of developing COPD in community-based settings.
引用
收藏
页码:1431 / 1440
页数:10
相关论文
共 50 条
  • [21] Safety of valproic acid in patients with chronic obstructive pulmonary disease: a population-based cohort study
    Antoniou, Tony
    Yao, Zhan
    Camacho, Ximena
    Mamdani, Muhammad M.
    Juurlink, David N.
    Gomes, Tara
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 (03) : 256 - 261
  • [22] Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study
    de Luise, Cynthia
    Brimacombe, Michael
    Pedersen, Lars
    Sorensen, Henrik Toft
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2008, 23 (02) : 115 - 122
  • [23] Exacerbation-like respiratory symptoms in individuals without chronic obstructive pulmonary disease: results from a population-based study
    Tan, W. C.
    Bourbeau, J.
    Hernandez, P.
    Chapman, K. R.
    Cowie, R.
    FitzGerald, J. M.
    Marciniuk, D. D.
    Maltais, F.
    Buist, A. S.
    O'Donnell, D. E.
    Sin, D. D.
    Aaron, S. D.
    THORAX, 2014, 69 (08) : 709 - 717
  • [24] Risk of Incident Chronic Obstructive Pulmonary Disease in Rheumatoid Arthritis: A Population-Based Cohort Study
    Mcguire, Katherine
    Avina-Zubieta, J. Antonio
    Esdaile, John M.
    Sadatsafavi, Mohsen
    Sayre, Eric C.
    Abrahamowicz, Michal
    Lacaille, Diane
    ARTHRITIS CARE & RESEARCH, 2019, 71 (05) : 602 - 610
  • [25] Dimensions of chronic respiratory symptoms in pre-school children: population-based birth cohort study
    Smith, J.
    Drake, R.
    Simpson, A.
    Woodcock, A.
    Pickkes, A.
    Custovic, A.
    ALLERGY, 2007, 62 : 425 - 425
  • [26] Chronic obstructive pulmonary disease and mortality following hip fracture: a population-based cohort study
    Cynthia de Luise
    Michael Brimacombe
    Lars Pedersen
    Henrik Toft Sørensen
    European Journal of Epidemiology, 2008, 23 : 115 - 122
  • [27] Incident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort study
    Vozoris, Nicholas T.
    Wang, Xuesong
    Fischer, Hadas D.
    Gershon, Andrea S.
    Bell, Chaim M.
    Gill, Sudeep S.
    O'Donnell, Denis E.
    Austin, Peter C.
    Stephenson, Anne L.
    Rochon, Paula A.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 81 (01) : 161 - 170
  • [28] Prevalence and correlates of chronic obstructive pulmonary disease and chronic respiratory symptoms in rural southwestern Uganda: a cross-sectional, population-based study
    North, Crystal M.
    Kakuhikire, Bernard
    Vorechovska, Dagmar
    Hausammann-Kigozi, Simone
    McDonough, Amy Q.
    Downey, Jordan
    Christiani, David C.
    Tsai, Alexander C.
    Siedner, Mark J.
    JOURNAL OF GLOBAL HEALTH, 2019, 9 (01)
  • [29] ARAPOC Study: Prevalence of respiratory symptoms and chronic obstructive pulmonary disease in the general population
    Bruscas Alijarde, M. Jose
    Naberan Tona, Karlos
    Lamban Sanchez, M. Teresa
    Bello Dronda, Salvador
    ATENCION PRIMARIA, 2015, 47 (06): : 336 - 343
  • [30] Smoking status and gene susceptibility play important roles in the development of chronic obstructive pulmonary disease and lung function decline A population-based prospective study
    Zhao, Junling
    Li, Miao
    Chen, Jinkun
    Wu, Xiaomei
    Ning, Qin
    Zhao, Jianping
    Xu, Yongjian
    Xie, Jungang
    Yu, Jun
    MEDICINE, 2017, 96 (25)